http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2417798-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc27e2b221d6517b7fd21efadec4c3a1
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
filingDate 2010-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2011-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3744d5e737dea74ff171829d7e19fa11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0658541d41ae76d7fa1c835afe53a497
publicationDate 2011-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2417798-C1
titleOfInvention Method of treating purulent arthritis with application of electro-activated water solutions: anolyte and catholyte
abstract FIELD: medicine. ^ SUBSTANCE: invention relates to medicine, namely to surgery, and deals with treatment of purulent arthritis. For this purpose carried out is intro-joint introduction of not less than 10ml of anolyte 0.3% NaCl with neutral Ph 7.3-7.7 and AFP +700-1100 mV. Said anolyte is introduced also paraorticularly in volume not less than 3 ml. Additionally perorally introduced is catholyte 0.3% NaCL with Ph 8.2-9.5 and AFP minus 450-600 mV. Catholyte introduction is carried out 3 times per day before meal in volume not less than 100 ml per intake. Treatment course constitutes not fewer than nine days. ^ EFFECT: method increases treatment efficiency, including at the background of post-traumatic hemarthrosis, synovitis, in absence of toxic action on joint and on surrounding it tissues and without application of pharmaco- and physiotherapy. ^ 5 tbl
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-024604-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2669461-C1
priorityDate 2010-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP12245
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12944
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409298605
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396842
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450235101
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP14847
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1401
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24341
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408264951
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO19062
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5353356
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524793
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID751795
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP02741
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP02742
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ07203
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24453
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID522325
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86598188
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID444374
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19094
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP48199
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665410
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP49254
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447722571
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526858
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP49262

Total number of triples: 48.